Atlas Trials

Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma

Clinical trial NCT06488482 · RECRUITING

Trial details

NCT number
NCT06488482
Sponsor
Uppsala University
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
High-risk Melanoma
Start date
2024-12-19
Primary completion
2030-09-01
Enrollment
1792

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.